SHARE

Loading Events

« All Events

BioWales in London pre-event

March 4 @ 1:00 pm - 5:00 pm

Mathys & Squire IP Firm,  The Shard, 32 London Bridge St, London SE1 9SG

4th March 2024

1 – 5pm

The afternoon before BioWales in London, MediWales will be holding a pre-event at the Shard, hosted by Mathys & Squire IP Firm.
Building on the conversations we had at our BioWales in Oxford event, in this event we will be discussing tech transfer, spin out, investment, IP and cluster development.

Please note registering for our BioWales in London event on the 5th March does not automatically register you for this event. You can register for our BioWales in London pre-event here.

 

Event programme:

1 – 1:30pm Registration and refreshments

 

1:30pm Welcome and Opening Presentations:

MediWales, Gwyn Tudor, CEO

Mathys & Squire

Sue Rees Associates, Sue Rees, Director

Welsh Government, Julie Russell, Business Development Manager, Inward Investment

 

2:30 – 3:30pm Panel Discussion: Spin Out, Growth and Raising Finance – Creating, financing and growing a successful life science business in Wales.

Development Bank of Wales, Mark Bowman, Venture Fund Manager

Creo Medical, Chris Hancock, CTO and Founder

Imspex Diagnostics, John McKinley, CEO

Oxford University Speaker

Swansea University Speaker

 

3:30 – 4pm Break

 

4 – 5pm Panel Discussion: Tech Transfer and Cluster Development – The vital role of research, industry, finance and healthcare and the networks that bring them together.

Development Bank of Wales, Richard Thomson, Senior Investment Executive

OMass Therapeutics, Jonathan Hopper, VP and Founder

EthicsGrade, Charles Radclyffe, CEO

PwC, Phil Sampson, Head of Deals

Cardiff Capital Region, Toby Williams, Cluster Development Manager

Mathys & Squire

 

Networking and close

Details

Date:
March 4
Time:
1:00 pm - 5:00 pm
Event Category:

Organiser

MediWales
Phone:
029 2047 3456
View Organiser Website

Venue

The Shard
The Shard, 32 London Bridge St
London, SE1 9SG United Kingdom
+ Google Map

MediWales Supporters:

Subscribe to our Mediwales newsletter